- Home
- ALPS vs HRTX Comparison
ALPS vs HRTX Comparison
Compare ALPS & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALPS | HRTX |
|---|---|---|
| Founded | 2017 | 1983 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.8M | 146.8M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | ALPS | HRTX |
|---|---|---|
| Price | $1.11 | $0.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 48.2K | ★ 2.1M |
| Earning Date | 07-24-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $154,904,000.00 |
| Revenue This Year | N/A | $15.28 |
| Revenue Next Year | N/A | $20.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.36 |
| 52 Week Low | $0.56 | $0.75 |
| 52 Week High | $1.72 | $2.61 |
Technical Indicators
Market Signals| Indicator | ALPS | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.25 | 22.92 |
| Support Level | $0.87 | N/A |
| Resistance Level | $1.11 | $1.41 |
| Average True Range (ATR) | 0.15 | 0.07 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 29.81 | 3.68 |
Price Performance
Historical ComparisonAbout ALPS ALPS Group Inc Ordinary Share
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.